Publication | Closed Access

Exploring of tumor-associated carbonic anhydrase isoenzyme IX and XII inhibitory effects and cytotoxicities of the novel N-aryl-1-(4-sulfamoylphenyl)-5-(thiophen-2-yl)-1H-pyrazole-3-carboxamides

Medicinal ChemistryBiochemistryMedicineNatural SciencesPharmacological AgentPharmacotherapyAnti-cancer AgentDrug DevelopmentXii Inhibitory EffectsPharmacologyPharmaceutical ChemistryNovel N-aryl-1-Drug Discovery